A Canadian MDMA production milestone has drawn attention to the next stage of psychedelic research. Here is what Phase 3 trials mean, how MDMA differs from psilocybin, and why approval is still not guaranteed.
Tag Archives: Health Canada
Interest in psychedelic therapy in Canada is expanding beyond veterans. Learn who is seeking support, what current evidence says, how legal access works, and why screening and professional care matter.


